Skip to main content
. 2022 Jun 29;13:948094. doi: 10.3389/fphys.2022.948094

FIGURE 2.

FIGURE 2

Schematic diagram showing the main dysregulated miRNAs and their corresponding downstream targets in various podocytopathies. Changes in miRNAs in podocytes occurring in focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), membranous nephropathy (MN), diabetic kidney diseases (DKD), and IgA nephropathy (IgAN). Dysregulation of indicated miRNAs contributes to podocyte injuries including podocyte foot process effacement and podocyte loss due to cell death or detachment from the glomerular basement membrane.